Ondansetron ODT 8 MG tablet 30S
Ended Awarded
- Contract number
- SPE2D326F307Q
- Awardee
-
Chartwell RX LLC UEI ER5UA9TYBGH4
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,285
Award facts
- Contract value 100% obligated
- $1,284.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Congers, NY 10920, USA
Award details come from SAM.gov/FPDS.
About this award
A Defense funding agency, listed in the source as Medical Supply Chain, issued a $1,284.50 delivery order to Chartwell RX LLC on July 27, 2026, for ondansetron ODT 8 MG tablets, 30-count (item 4572500341). The order is priced firm fixed price, with an ultimate completion date of July 28, 2026. Place of performance is Congers, NY 10920, USA. No set-aside was used.
Quick answers
Who was awarded contract SPE2D326F307Q?
SPE2D326F307Q was awarded to Chartwell RX LLC by Medical Supply Chain (Troop Support) on July 27, 2026.
How much is contract SPE2D326F307Q worth?
The government has obligated $1,285 on SPE2D326F307Q.
Is contract SPE2D326F307Q an order under another contract?
Yes. SPE2D326F307Q is a delivery order under SPE2D020D0005, an indefinite delivery contract.
Was contract SPE2D326F307Q competed?
The extent of competition for SPE2D326F307Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award